datelliptium chloride has been researched along with Leukemia L 1210 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Djuric, Z; Everett, CK; Valeriote, FA | 1 |
| Biernat, LA; Corbett, TH; Mucci-LoRusso, P; Polin, L; Valeriote, FA | 1 |
| Auclair, C; Colas, C; Cros, S; Gros, P; Paoletti, C; Pepin, O; Pierre, A; Saucier, JM; Verschuere, B; Voisin, E | 1 |
3 other study(ies) available for datelliptium chloride and Leukemia L 1210
| Article | Year |
|---|---|
DNA damage and cytotoxicity in L1210 cells by ellipticine and a structural analogue, N-2-(diethylaminoethyl)-9-hydroxyellipticinium chloride.
Topics: Animals; DNA Damage; DNA Repair; DNA, Neoplasm; DNA, Single-Stranded; Drug Screening Assays, Antitumor; Ellipticines; Leukemia L1210 | 1992 |
Activity of datelliptium acetate (NSC 311152; SR 95156A) against solid tumors of mice.
Topics: Adenocarcinoma; Animals; Carcinoma, Intraductal, Noninfiltrating; Colonic Neoplasms; Drug Screening Assays, Antitumor; Ellipticines; Female; Humans; Injections, Intravenous; Leukemia L1210; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Experimental; Pancreatic Neoplasms | 1990 |
Physicochemical and pharmacological properties of the antitumor ellipticine derivative 2-(diethylamino-2-ethyl)9-hydroxy ellipticinium-chloride, HCl.
Topics: Adenocarcinoma; Alkaloids; Animals; Antineoplastic Agents; Cell Line; Chemical Phenomena; Chemistry, Physical; Colonic Neoplasms; DNA; Ellipticines; Leukemia L1210; Leukemia P388; Melanoma; Mutagenicity Tests; Salmonella | 1987 |